Evidence map›Paper›PMID 27338296›Full record

ArticlePsychological medicine2016

Risperidone-induced topological alterations of anatomical brain network in first-episode drug-naive schizophrenia patients: a longitudinal diffusion tensor imaging study.

M Hu, X Zong, J Zheng, J J Mann, Z Li, S P Pantazatos, Y Li, Y Liao, Y He, J Zhou and 6 more

Abstract read
In one paragraph

Article in Psychological medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Functional brain networks in never-treated and treated long-term Ill schizophrenia patients.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

M HuMental Health Institute of the Second Xiangya Hospital,Central South University,139 Middle Renmin Road,Changsha,Hunan 410011,People's Republic of China.
X ZongMental Health Institute of the Second Xiangya Hospital,Central South University,139 Middle Renmin Road,Changsha,Hunan 410011,People's Republic of China.
J ZhengKey Laboratory for NeuroInformation of the Ministry of Education,School of Life Science and Technology,University of Electronic Science and Technology of China,Chengdu 610054,People's Republic of China.
J J MannDivision of Molecular Imaging and Neuropathology,New York State Psychiatric Institute and Departments of Psychiatry and Radiology,Columbia University,1051 Riverside Drive,Box 42,New York,NY 10032,USA.
Z LiMental Health Institute of the Second Xiangya Hospital,Central South University,139 Middle Renmin Road,Changsha,Hunan 410011,People's Republic of China.
S P PantazatosDivision of Molecular Imaging and Neuropathology,New York State Psychiatric Institute and Departments of Psychiatry,Columbia University,New York, NY 10032,USA.
Y LiKey Laboratory for NeuroInformation of the Ministry of Education,School of Life Science and Technology,University of Electronic Science and Technology of China,Chengdu 610054,People's Republic of China.
Y LiaoMental Health Institute of the Second Xiangya Hospital,Central South University,139 Middle Renmin Road,Changsha,Hunan 410011,People's Republic of China.
Y HeMental Health Institute of the Second Xiangya Hospital,Central South University,139 Middle Renmin Road,Changsha,Hunan 410011,People's Republic of China.
J ZhouMental Health Institute of the Second Xiangya Hospital,Central South University,139 Middle Renmin Road,Changsha,Hunan 410011,People's Republic of China.
D SangDepartment of Radiology,Henan Mental Hospital, the Second Affiliated Hospital of Xinxiang Medical University,Xinxiang,Henan 453002,People's Republic of China.
H ZhaoDepartment of Radiology,Henan Mental Hospital, the Second Affiliated Hospital of Xinxiang Medical University,Xinxiang,Henan 453002,People's Republic of China.
J TangMental Health Institute of the Second Xiangya Hospital,Central South University,139 Middle Renmin Road,Changsha,Hunan 410011,People's Republic of China.
H ChenKey Laboratory for NeuroInformation of the Ministry of Education,School of Life Science and Technology,University of Electronic Science and Technology of China,Chengdu 610054,People's Republic of China.
L LvDepartment of Psychiatry,Henan Mental Hospital, the Second Affiliated Hospital of Xinxiang Medical University,Xinxiang,Henan 453002,People's Republic of China.
X ChenMental Health Institute of the Second Xiangya Hospital,Central South University,139 Middle Renmin Road,Changsha,Hunan 410011,People's Republic of China.
Central South University · CNUniversity of Electronic Science and Technology of China · CNHenan Psychiatric Hospital · CNSecond Xiangya Hospital of Central South University · CNColumbia University · USNew York Psychoanalytic Society and Institute · USXinxiang Medical University · CN

Funding

Integrative neuroinformatics to relate genomics to neurocircuitry and psychopathologyK01MH108721 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI PANTAZATOS, SPIRO PETER · 2016 to 2019
$739k
NIMH NIH HHS K01 MH108721
6 · The paper itself

Abstract

backgroundIt remains unclear whether the topological deficits of the white matter network documented in cross-sectional studies of chronic schizophrenia patients are due to chronic illness or to other factors such as antipsychotic treatment effects. To answer this question, we evaluated the white matter network in medication-naive first-episode schizophrenia patients (FESP) before and after a course of treatment.

methodWe performed a longitudinal diffusion tensor imaging study in 42 drug-naive FESP at baseline and then after 8 weeks of risperidone monotherapy, and compared them with 38 healthy volunteers. Graph theory was utilized to calculate the topological characteristics of brain anatomical network. Patients' clinical state was evaluated using the Positive and Negative Syndrome Scale (PANSS) before and after treatment.

resultsPretreatment, patients had relatively intact overall topological organizations, and deficient nodal topological properties primarily in prefrontal gyrus and limbic system components such as the bilateral anterior and posterior cingulate. Treatment with risperidone normalized topological parameters in the limbic system, and the enhancement positively correlated with the reduction in PANSS-positive symptoms. Prefrontal topological impairments persisted following treatment and negative symptoms did not improve.

conclusionsDuring the early phase of antipsychotic medication treatment there are region-specific alterations in white matter topological measures. Limbic white matter topological dysfunction improves with positive symptom reduction. Prefrontal deficits and negative symptoms are unresponsive to medication intervention, and prefrontal deficits are potential trait biomarkers and targets for negative symptom treatment development.

Indexed as

Limbic SystemNerve NetPrefrontal CortexSchizophreniaWhite MatterAdolescentAdultAntipsychotic AgentsDiffusion Tensor ImagingFollow-Up StudiesHumansLongitudinal StudiesRisperidoneYoung AdultAntipsychotic AgentsRisperidoneFirst-episode schizophrenialongitudinal studiesnetworksschizophreniatopologywhite matter

Identifiers

PMID27338296
PMCPMC5242555
OpenAlexW2474016060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.